<DOC>
	<DOCNO>NCT00384605</DOCNO>
	<brief_summary>A 1 year worldwide study obese overweight patient assess safety effect body weight investigational weight loss drug .</brief_summary>
	<brief_title>An Investigational Drug Study Assess Weight Loss Obese Overweight Patients ( 0364-037 ) ( TERMINATED )</brief_title>
	<detailed_description />
	<mesh_term>Obesity</mesh_term>
	<mesh_term>Overweight</mesh_term>
	<criteria>Male female , 18 year age old , Body Mass Index ( BMI ) 30 kg/m2 43 kg/m2 , inclusive ( BMI 27 kg/m2 43 kg/m2 , inclusive , obesityrelated comorbidities ) . Obesityrelated comorbidities associate BMI 27 kg/m2 high include hypertension , dyslipidemia sleep apnea Stable weight ( +/3 kg ) least 3 month prior study start History diabetes mellitis , major psychiatric disorder , significant cardiovascular disease , stroke , TIA , neurological disorder , nonfebrile seizure Screening systolic blood pressure &gt; 160 mm Hg diastolic blood pressure &gt; 100 mm Hg</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>